Utility of FDG-PETCT and magnetic resonance spectroscopy in differentiating between cerebral lymphoma and non-malignant CNS lesions in HIV-infected patients

European Journal of Radiology

Volumn 82, Issue 8, 2013, Pages

  Westwood, Thomas D ^a   Hogan, Celia ^b   Julyan, Peter J ^a   Coutts, Glyn ^a   Bonington, Suzie ^a   Carrington, Bernadette ^a   Taylor, Ben ^a   Khoo, Saye ^c   Bonington, Alec ^b  

^a CHRISTIE HOSPITAL   (United Kingdom)

^b NORTH MANCHESTER GENERAL HOSPITAL   (United Kingdom)

^c ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Central nervous system; HIV; Lymphoma; Magnetic resonance spectroscopy; Positron emission tomography and computed tomography

Indexed keywords

FLUORODEOXYGLUCOSE; BIOLOGICAL MARKER; FLUORODEOXYGLUCOSE F 18; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; ARTICLE; BRAIN BIOPSY; BRAIN METASTASIS; CENTRAL NERVOUS SYSTEM DISEASE; CENTRAL NERVOUS SYSTEM TUMOR; CLINICAL ARTICLE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; NEUROLOGIC DISEASE; NON MALIGNANT CENTRAL NERVOUS SYSTEM LESION; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; PROSPECTIVE STUDY; TOXOPLASMOSIS; TREATMENT RESPONSE; BRAIN DISEASES; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC USE; DIFFERENTIAL DIAGNOSIS; HIV INFECTIONS; LYMPHOMA, AIDS-RELATED; METABOLISM; MULTICENTER STUDY; MULTIMODAL IMAGING; POSITRON EMISSION TOMOGRAPHY; PROCEDURES; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; UNITED KINGDOM;

ADULT; BIOLOGICAL MARKERS; BRAIN DISEASES; DIAGNOSIS, DIFFERENTIAL; FEMALE; FLUORODEOXYGLUCOSE F18; GREAT BRITAIN; HIV INFECTIONS; HUMANS; LYMPHOMA, AIDS-RELATED; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MULTIMODAL IMAGING; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84879498752     PISSN: 0720048X     EISSN: 18727727     Source Type: Journal    
DOI: 10.1016/j.ejrad.2013.03.008     Document Type: Article

References (25)

1. U. Herrlinger Primary central nervous system lymphoma: from clinical presentation to diagnosis Journal of Neuro-Oncology 43 1999 219 226
2. J. Berger Mass lesions of the brain in AIDS: the dilemmas of distinguishing toxoplasmosis from primary CNS lymphoma American Journal of Neuroradiology 24 2003 554 555
3. G. Lee Cerebral toxoplasmosis Radiographics 29 2009 1200 1205
4. D. Tate The role of medical imaging in defining CNS abnormalities associated with HIV-infection and opportunistic infections Neurotherapeutics 8 2011 103 116
5. I.S. Haldorsen Central nervous system lymphoma: characteristic findings on traditional and advanced imaging American Journal of Neuroradiology 32 2011 984 992
6. R. Gupta MR imaging and spectroscopy of central nervous system infection 2001 Kluwer Academic/Plenum New York
7. A. Kulkarni Incidence of silent haemorrhage and delayed deterioration after stereotactic brain biopsy Journal of Neurosurgery 89 1998 31 35
8. M. McGirt Independent predictors of morbidity after image-guided stereotactic brain biopsy: a risk assessment of 270 cases Journal of Neurosurgery 102 2005 897 901
9. Centers for Disease Control and Prevention. Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America, April 10, 2009.
10. M. Bower Treatment outcome in presumed and confirmed AIDS-related primary cerebral lymphoma European Journal of Cancer 35 4 1999 601 604
11. I. Haldorsen Diagnostic delay in primary central nervous system lymphoma Acta Oncologica 44 7 2005 728 734
12. J.L. Go Imaging of primary central nervous system lymphoma Neurosurgical Focus 21 5 2006 984 992
13. H.W. Sloane CT and MRI findings of intracranial lymphoma American Journal of Roentgenology 184 5 2005 1679 1685
14. L. Chang Radiologic-pathologic correlation: cerebral toxoplasmosis and lymphoma in AIDS American Journal of Neuroradiology 16 1995 1653 1663
15. T.T. Zaxharia Central nervous system lymphoma characterization by diffusion weighted imaging and MR spectroscopy Journal of Neuroimaging 18 4 2008 411 417
16. D.L. Camacho Differentiation of toxoplasmosis and lymphoma in AIDS patients by using apparent diffusion coefficients American Journal of Neuroradiology 24 4 2003 633 637
17. R. Kessler Evaluating contrast-enhancing brain lesions in patients with AIDS by using positron emission tomography Annals of Internal Medicine 123 8 1995 594 598
18. A.E. Heald Differentiation of central nervous system lesions in AIDS patients using positron emission tomography (PET) International Journal of STD & AIDS 7 1996 337 346
19. S. Taillibert Brain lymphoma: usefulness of the magnetic resonance spectroscopy Journal of Neuro-Oncology 86 2 2008 225 229
20. L. Chang, and T. Ernst TMR spectroscopy and diffusion-weighted MR imaging in focal brain lesions in AIDS Neuroimaging Clinics of North America 7 3 1997 409 426
21. M.G. Pomper Quantitative MR spectroscopic imaging of brain lesions in patients with AIDS Academic Radiology 9 2002 398 409
22. E. Rohren Screening for cerebral metastases with FDG PET in patients undergoing whole-body staging of non-central nervous system malignancy Radiology 226 2003 181 187
23. L. Griffeth Brain metastases from non-central nervous system tumours: evaluation with PET Radiology 186 1993 37 44
24. T. Thiel Phase coherent averaging in magnetic resonance spectroscopy using interleaved navigator scans: compensation for motion artefacts and magnetic field instabilities Magnetic Resonance in Medicine 47 6 2002 1077 1082
25. C. Besson Changes in AIDS-related lymphoma since the era of highly active antiretroviral therapy Blood 98 2001 2339 2344